Navigating Treatment Challenges: A Case Study on Refractory Psychosis in a Chronic MDMA (3,4-Methylenedioxymethamphetamine) User.

A 23-year-old woman with chronic MDMA use disorder and childhood trauma developed severe psychosis and catatonia. Although initially suspected to be drug-induced psychosis, her history and symptoms led to a diagnosis of bipolar I disorder with psychotic features, worsened by MDMA use. Standard antipsychotics failed and worsened catatonia, requiring electroconvulsive therapy (ECT) for improvement. Socioeconomic barriers disrupted follow-up care, resulting in an emergency department visit shortly after discharge. The case illustrates the complex interaction of substance use, psychiatric illness, and trauma, highlights ECT's effectiveness in severe psychosis, and underscores the need for comprehensive mental health services for vulnerable populations and further research on MDMA's psychiatric effects.

Study at a glance

Abstract

MDMA (3,4-methylenedioxy​methamphetamine), also known as Ecstasy, is a synthetic amphetamine with hallucinogenic and stimulant properties, which has become increasingly favored as a substance for recreational use. Despite its deceptive reputation as "safe," chronic MDMA use is associated with neuropsychiatric complications, including psychosis. We describe a case of a 23-year-old woman with chronic MDMA use disorder and childhood trauma, who presented with severe psychosis and catatonic features. While initial diagnostic possibilities included drug-induced psychosis and mood disorders, the patient's history and presentation supported a diagnosis of bipolar I disorder with psychotic features, which was exacerbated by MDMA use. Conventional antipsychotics failed to improve psychotic symptoms and led to worsening of catatonia, requiring electroconvulsive therapy (ECT) for improvement. Socioeconomic barriers hindered follow-up care, leading to an Emergency Department (ED) admission shortly after discharge. This case highlights the intricate interplay between substance use, psychiatric illness, and trauma, and showcases ECT's efficacy in severe psychosis. It emphasizes the necessity for comprehensive mental health services, especially for vulnerable populations, and calls for further research into MDMA's psychiatric effects and optimal treatment approaches for individuals with co-occurring substance use and psychiatric disorders.